Walter Schmidt
Directeur/Bestuurslid bij Advantage Therapeutics, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jeff Madden | M | - |
Advantage Therapeutics, Inc.
 Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| Frank Mattner | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| David Buchsbaum | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| Agustin Fernandez Santana | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | - |
| James O'Neill | M | - |
Advantage Therapeutics, Inc.
Advantage Therapeutics, Inc. Medical SpecialtiesHealth Technology ADvantage Therapeutics, Inc. is an American biotech company that focuses on developing therapies to treat neurodegenerative conditions, specifically Alzheimer's disease. The company was founded in 2021 and is based in an undisclosed location. The company's subsidiary, ADvantage Therapeutics GmbH, conducts early research and drug development. The company is developing a novel immunotherapy for early Alzheimer's disease. The company was founded by Jeffrey Bartley Madden and Agustin Fernandez Santana, with Jeffrey Bartley Madden serving as the CEO since incorporation. | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 5 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Walter Schmidt
- Persoonlijk netwerk
